Northrop Grumman Corporation — Q2 2022 Form 10-Q Summary
Business Context and Reporting Period
Northrop Grumman is a global aerospace and defense company serving primarily the U.S. Department of Defense, intelligence community and international customers. The filing covers the three and six months ended June 30, 2022. Results reflect four reportable segments: Aeronautics Systems, Defense Systems, Mission Systems and Space Systems.
The prior-year comparison is affected by the January 2021 divestiture of the IT and mission support services business, which generated $3.4 billion of cash proceeds and a $2.0 billion pretax gain in 2021.
Financial Performance and Liquidity
| Metric | Q2 2022 | Q2 2021 | Six Months 2022 | Six Months 2021 |
|---|---|---|---|---|
| Sales | $8.801 billion | $9.151 billion | $17.598 billion | $18.308 billion |
| Operating income | $954 million | $1.044 billion | $1.851 billion | $3.866 billion |
| Operating margin | 10.8% | 11.4% | 10.5% | 21.1% |
| Net earnings | $946 million | $1.037 billion | $1.901 billion | $3.232 billion |
| Diluted EPS | $6.06 | $6.42 | $12.16 | $19.89 |
| Operating cash flow | Not separately provided | Not separately provided | $(685) million | $962 million |
| Adjusted free cash flow | Not separately provided | Not separately provided | $(1.192) billion | $583 million |
- Q2 sales declined 4%, operating income declined 9%, and net earnings declined 9% year over year. The six-month operating income comparison was reduced by the prior-year $2.0 billion divestiture gain.
- Six-month organic sales, excluding the divested IT services business, declined 3%. Segment organic sales decreased 11% at Aeronautics Systems and Defense Systems, 2% at Mission Systems, and increased 11% at Space Systems.
- Six-month cash flow from operations was negative because of working-capital investment, delayed customer payments and approximately $450 million of federal tax payments related to IRC Section 174. Capital expenditures were $507 million.
- Cash and cash equivalents were $1.169 billion at June 30, 2022, compared with $3.530 billion at December 31, 2021. Long-term debt was $12.834 billion, and estimated fair value of long-term debt was $12.8 billion.
- No commercial paper or credit-facility borrowings were outstanding. The company had a $2.0 billion senior unsecured credit facility, and management stated that available liquidity and financing sources are expected to be sufficient for short- and long-term needs.
- The company repurchased $640 million of common stock during the first six months and increased its quarterly dividend 10% to $1.73 per share. Total outstanding repurchase authorization was $3.5 billion at June 30, 2022.
Segment Results and Material Changes
| Segment | Q2 Sales | Q2 Sales Change | Q2 Operating Margin |
|---|---|---|---|
| Aeronautics Systems | $2.534 billion | (13%) | 10.2% |
| Defense Systems | $1.294 billion | (9%) | 13.0% |
| Mission Systems | $2.516 billion | (3%) | 16.4% |
| Space Systems | $2.979 billion | 8% | 10.4% |
- Aeronautics Systems was affected by lower volume on restricted programs, F-35, Global Hawk and NATO AGS programs.
- Defense Systems declined because of program completions, lower international training activity and wind-down of UKAWACS and JSTARS programs.
- Mission Systems margin improved, including a $33 million benefit related to a contract legal matter.
- Space Systems growth was driven by ramp-up on Next Generation Interceptor and Ground Based Strategic Deterrent development programs. Margin declined because of the mix of early-stage development work and lower favorable contract adjustments.
- Aggregate favorable estimate-at-completion adjustments contributed $265 million of operating income in the first six months, including a $67 million favorable B-21 adjustment recorded in the first quarter. No material EAC adjustments occurred in Q2.
- Backlog increased 5% from year-end 2021 to approximately $80.0 billion, including $34.4 billion funded and $45.6 billion unfunded. Management expects approximately 40% of backlog to convert to revenue within 12 months and 60% within 24 months.
Outlook, Risks, Contingencies and Unusual Items
- Management stated that labor shortages, extended material lead times, inflation and supply-chain disruption reduced Q2 revenue and operating income and are expected to continue.
- The company was not assuming significant additional direct COVID-19 impacts on 2022 results, but continued to identify pandemic-related labor, supply-chain, cost-recovery and performance risks.
- Management cited heightened global security tensions and the Ukraine conflict as potential sources of increased demand, but also noted supply-chain disruption and unanticipated cost growth, including on the Commercial Resupply Services contract.
- If IRC Section 174 research-and-development amortization requirements are not deferred retroactively, the company estimated an approximately $1 billion reduction in 2022 operating cash flow. The actual effect depends on future legislation, IRS guidance and 2022 R&D spending.
- Unrecognized tax benefits were approximately $1.7 billion at June 30, 2022, including $458 million related to IRC Section 451(b). Unfavorable resolution could materially affect future cash flows.
- Bethpage, New York environmental remediation liabilities were accrued at $574 million, with $363 million of reasonably possible future costs in excess of accrued amounts. The company stated that costs could increase materially if remediation requirements or facts change.
- A U.S. Court of Federal Claims decision awarded the company approximately $63 million of unpaid contract amounts, $5 million of additional damages and approximately $15 million of interest, subject to the government’s motion for reconsideration and potential appeal.
- The company faces continuing government contract, tax, environmental, litigation, cybersecurity, workforce, supplier, appropriation and program-execution risks. Management could not estimate the cumulative potential liability of the Bethpage lawsuits.
Important Facts for Investors to Verify
- Whether customer-payment timing, working-capital investment and IRC Section 174 taxes normalize sufficiently to restore positive operating and free cash flow.
- Progress on Aeronautics Systems and Defense Systems recovery, including restricted programs, F-35, Triton and other production and development programs.
- Space Systems execution, margin recovery and profitability of NGI, GBSD and other early-stage development programs.
- The sustainability of favorable EAC adjustments, including the B-21 adjustment and the $33 million Mission Systems legal-related benefit.
- Resolution and cash impact of tax audits, unrecognized tax benefits, the Section 174 requirement and the CAS pension-interest-rate matter.
- Changes in Bethpage remediation costs, environmental claims and related recoverability through U.S. government contract overhead.
- Actual funding and conversion of the $80.0 billion backlog, particularly its large unfunded component.
- Impact of inflation, labor constraints, supply-chain disruptions, Ukraine-related developments and U.S. defense-budget decisions on contract costs, schedules and margins.